Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Rating of “Hold” by Brokerages

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been given an average recommendation of “Hold” by the eighteen research firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, twelve have issued a hold recommendation and five have given a buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $9.50.

A number of research analysts have recently weighed in on TDOC shares. Evercore ISI lowered their price target on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a report on Thursday, October 30th. Weiss Ratings restated a “sell (e+)” rating on shares of Teladoc Health in a research report on Monday, December 29th. Barclays initiated coverage on Teladoc Health in a research note on Tuesday, December 9th. They set an “equal weight” rating and a $8.50 target price on the stock. Citigroup dropped their target price on Teladoc Health from $10.00 to $9.00 and set a “neutral” rating on the stock in a report on Friday. Finally, BMO Capital Markets assumed coverage on shares of Teladoc Health in a report on Thursday, November 13th. They set a “market perform” rating and a $8.00 price target for the company.

Teladoc Health Stock Down 2.0%

TDOC stock opened at $7.46 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60. The firm has a market capitalization of $1.32 billion, a P/E ratio of -5.82 and a beta of 2.04. Teladoc Health has a 52-week low of $6.35 and a 52-week high of $15.21. The company’s 50 day simple moving average is $7.38 and its 200-day simple moving average is $7.81.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The firm had revenue of $626.44 million during the quarter, compared to analyst estimates of $625.66 million. During the same quarter last year, the business posted ($0.19) EPS. The company’s revenue was down 2.2% on a year-over-year basis. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. As a group, equities research analysts anticipate that Teladoc Health will post -1.16 EPS for the current year.

Insider Activity at Teladoc Health

In other news, insider Fernando M. Rodrigues sold 4,209 shares of the company’s stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total value of $31,483.32. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Charles Divita III sold 17,138 shares of the stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $7.63, for a total value of $130,762.94. Following the sale, the chief executive officer owned 201,036 shares of the company’s stock, valued at approximately $1,533,904.68. This represents a 7.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 33,288 shares of company stock worth $251,684 in the last quarter. 0.58% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Y Intercept Hong Kong Ltd bought a new position in Teladoc Health during the second quarter valued at about $2,722,000. Farther Finance Advisors LLC boosted its stake in shares of Teladoc Health by 424.5% during the 2nd quarter. Farther Finance Advisors LLC now owns 9,960 shares of the health services provider’s stock worth $87,000 after acquiring an additional 8,061 shares in the last quarter. Ameritas Advisory Services LLC acquired a new position in shares of Teladoc Health during the 2nd quarter valued at about $78,000. Wealth Management Associates Inc. bought a new position in shares of Teladoc Health in the 2nd quarter valued at approximately $509,000. Finally, Strs Ohio bought a new position in shares of Teladoc Health in the 1st quarter valued at approximately $349,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.